How Oncologists and Pathologists Can Best Collaborate to Provide Precision Medicine for Their Patients

David Spigel, MD

Video Categories: 2018 ASCO Insights and Video Library

Dr David Spigel discusses how medical oncologists and the rest of the cancer care team can best communicate with pathologists to help make informed treatment decisions for individual patients and set up new assays for emerging biomarkers as they are discovered.

January 30, 2014

Providing the Right Information on Target Therapy to the Oncology Community

Dr Agarwala discusses the optimal approach to providing information on targeted therapies to the oncology community.

July 25, 2018

Biomarker Data in Melanoma Presented at ASCO 2018 Are Largely Extensions of Previous Studies Rather Than New Discoveries

Dr Sanjiv Agarwala argues that much of the biomarker data in melanoma presented at ASCO 2018 are around the value of PD-L1 testing; however, even PD-L1–negative melanoma patients seem to respond to anti–PD-1 therapy, although some studies suggest PD-L1–negative patients may be better candidates for combination immunotherapy.